Inventor
Barry S. Coller
Inventor
New York, NY, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
C07KPeptides23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C07DHeterocyclic compounds9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
A61LMethods or apparatus for sterilising materials or objects in general2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
10,450,375Methods of treating sickle cell disease20199,532,989'Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines'20179,506,938'Methods for measuring platelet reactivity of individuals treated with drug eluting stents'20169,341,637'Controlled platelet activation to monitor therapy of ADP antagonists'20169,303,044'7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders'20169,073,945'Alpha-IIb-beta-3 inhibitors and uses thereof'20159,066,948'Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines'20158,574,828'Controlled platelet activation to monitor therapy of ADP antagonists'20138,173,661'Alpha-IIB-beta-3 inhibitors and uses thereof'20127,790,362'Controlled platelet activation to monitor therapy of ADP antagonists'20105,976,532'Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3'19995,877,006'DNAs encoding chimeric immunoglobulin light or heavy chains and fragments thereof having variable regions derived from monoclonal antibody 7E3, and vectors and host cells comprising same'19995,854,005'Platelet blockade assay'19985,770,198'Platelet-specific chimeric 7E3 immunoglobulin'19985,763,199'Platelet blockade assay'19985,455,228'Peptidase resistant thrombin receptor peptide ligand'19955,440,020'Platelet function inhibiting monoclonal antibody fragment'19955,387,413'Method of inhibiting thrombus formation by the 7E3 monoclonal antibody'19955,338,725'Anti-aggregatory agents for platelets'19945,336,618'Fibrinogen blocking monoclonal antibody'19945,328,840'Method for preparing targeted carrier erythrocytes'19945,275,812'Method of treatment for myocardial infarction'19945,225,181'Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–1995Patents assigned to UNIV NEW YORK STATE RES FOUND (7)· patent assignee history
1993–1999Based in Dix Hills, NY, US· patent location history
1998–2019Based in New York, NY, US· patent location history
2010–2016Patents assigned to ACCUMETRICS INC (4)· patent assignee history
2012–2019Patents assigned to COLLER BARRY S (6)· patent assignee history
2012–2017Patents assigned to UNIV ROCKEFELLER (5)· patent assignee history
2015–2019Patents assigned to ICAHN SCHOOL MED MOUNT SINAI (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV NEW YORK STATE RES FOUND | 7 | 1993–1995 |
| COLLER BARRY Sself | 6 | 2012–2019 |
| UNIV ROCKEFELLER | 5 | 2012–2017 |
| ACCUMETRICS INC | 4 | 2010–2016 |
| ICAHN SCHOOL MED MOUNT SINAI | 4 | 2015–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 12 | 1998–2019 |
| Dix Hills, New York, US | 11 | 1993–1999 |